CROMSOURCE Consolidates Hybrid Services Model

Published on: 

Applied Clinical Trials

CROMSOURCE has announced consolidation of its Hybrid Services Model and refined it to be able to provide its pharmaceutical, medical device, and biotechnology clients with an efficient alternative to traditional fully outsourced or functional service provider models.

To learn more, click here.